Emergent BioSolutions’ stock soars 23% after FDA approves its smallpox vaccine for mpox
The Emergent vaccine is now the second one to win FDA approval after one developed by Danish biotech Bavarian Nordic.
The Emergent vaccine is now the second one to win FDA approval after one developed by Danish biotech Bavarian Nordic.
